Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial

• Brian E. Lacy,

  Affiliation Dartmouth-Hitchcock Medical Center, Lebanon, NH, United States of America

  ⨯
• Ron Schey,

  Affiliation University of Iowa Hospitals and Clinics, Iowa City, IA, United States of America

  ⨯
• Steven J. Shiff,

  Affiliation Forest Laboratories LLC, a subsidiary of Actavis plc, Jersey City, NJ, United States of America

  ⨯
• Bernard J. Lavins,

  Affiliation Ironwood Pharmaceuticals, Cambridge, MA, United States of America

  ⨯
• Susan M. Fox,

  Affiliation Forest Laboratories LLC, a subsidiary of Actavis plc, Jersey City, NJ, United States of America

  ⨯
• Xinwei D. Jia,

  Affiliation Forest Laboratories LLC, a subsidiary of Actavis plc, Jersey City, NJ, United States of America

  ⨯
• Rick E. Blakesley,

  Affiliation Forest Laboratories LLC, a subsidiary of Actavis plc, Jersey City, NJ, United States of America

  ⨯
• Xinming Hao,

  Affiliation Ironwood Pharmaceuticals, Cambridge, MA, United States of America

  ⨯
• Jacquelyn A. Cronin ,

  * E-mail: jcronin@ironwoodpharma.com

  Affiliation Ironwood Pharmaceuticals, Cambridge, MA, United States of America

  ⨯
• Mark G. Currie,

  Affiliation Ironwood Pharmaceuticals, Cambridge, MA, United States of America

  ⨯
• Caroline B. Kurtz,

  Affiliation Ironwood Pharmaceuticals, Cambridge, MA, United States of America

  ⨯
• Jeffrey M. Johnston,

  Affiliation Ironwood Pharmaceuticals, Cambridge, MA, United States of America

  ⨯
• Anthony J. Lembo

  Affiliation Beth Israel Deaconess Medical Center, Boston, MA, United States of America

  ⨯